Wechselwirkungen zwischen parodontalen und systemischen Erkrankungen^[*]

Lernziele

Nach dem Durcharbeiten des Artikels sollte der Leser

• wissen, welche systemischen Erkrankungen mit der Parodontitis assoziiert sind,

• dem Patienten den Zusammenhang seiner Parodontitis mit anderen Erkrankungen erklären können und

• sich über die Rolle der Parodontitis-Behandlung auch für die Gesamtgesundheit des Menschen bewusst geworden sein.

• Literatur

• 1 Blaizot A, Vergnes JN, Nuwwareh S et al. Periodontal diseases and cardiovascular events: meta-analysis of observational studies. Int Dent J 2009; 59: 197-209
• 2 Darré L, Vergnes JN, Gourdy P et al. Efficacy of periodontal treatment on glycaemic control in diabetic patients: A meta-analysis of interventional studies. Diabetes Metab 2008; 34: 497-506
• 3 Graves DT, Liu R, Oates TW. Diabetes-enhanced inflammation and apoptosis: impact on periodontal pathosis. Periodontol 2000 2007; 45: 128-137
• 4 Janket SJ, Baird AE, Chuang SK et al. Meta-analysis of periodontal disease and risk of coronary heart disease and stroke. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 95: 559-569
• 5 Janket SJ, Wightman A, Baird AE et al. Does periodontal treatment improve glycemic control in diabetic patients? A meta-analysis of intervention studies. J Dent Res 2005; 84: 1154-1159
• 6 Khader YS, Albashaireh ZS, Alomari MA. Periodontal diseases and the risk of coronary heart and cerebrovascular diseases: a meta-analysis. J Periodontol 2004; 75: 1046-1053
• 7 Khader YS, Dauod AS, El-Qaderi SS et al. Periodontal status of diabetics compared with nondiabetics: a meta-analysis. J Diabetes Complications 2006; 20: 59-68
• 8 Lalla E, Lamster IB, Feit M et al. Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice. J Clin Invest 2000; 105: 1117-1124
• 9 Libby P. Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr 2006; 83
• 10 Mealey BL, Ocampo GL. Diabetes mellitus and periodontal disease. Periodontol 2000 2007; 44: 127-153
• 11 Nishimura F, Iwamoto Y, Soga Y. The periodontal host response with diabetes. Periodontol 2000 2007; 43: 245-253
• 12 Offenbacher S, Boggess KA, Murtha AP et al. Progressive periodontal disease and risk of very preterm delivery. Obstet Gynecol 2006; 107: 29-36
• 13 Page RC, Kornman KS. The pathogenesis of human periodontitis: an introduction. Periodontol 2000 1997; 14: 9-11
• 14 Preshaw PM, Foster N, Taylor JJ. Cross-susceptibility between periodontal disease and type 2 diabetes mellitus: an immunobiological perspective. Periodontol 2000 2007; 45: 138-157
• 15 Rohlfing CL, Wiedmeyer HM, Little RR et al. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. Diabetes Care 2002; 25: 275-278
• 16 Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87: 4-14
• 17 Taylor GW, Burt BA, Becker MP et al. Glycemic control and alveolar bone loss progression in type 2 diabetes. Ann Periodontol 1998; 3: 30-39
• 18 Teeuw WJ, Gerdes VE, Loos BG. Effect of periodontal treatment on glycemic control of diabetic patients: a systematic review and meta-analysis. Diabetes Care 2010; 33: 421-427
• 19 Tervonen T, Karjalainen K. Periodontal disease related to diabetic status. A pilot study of the response to periodontal therapy in type 1 diabetes. J Clin Periodontol 1997; 24: 505-510
• 20 Tonetti MS, D'Aiuto F, Nibali L et al. Treatment of periodontitis and endothelial function. N Engl J Med 2007; 356: 911-920
• 21 Tsai C, Hayes C, Taylor GW. Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population. Community Dent Oral Epidemiol 2002; 30: 182-192
• 22 Vergnes JN, Sixou M. Preterm low birth weight and maternal periodontal status: a meta-analysis. Am J Obstet Gynecol 2007; 196: 1-7